Sociodemographic, Constitutional Risk Factors Associated with Likelihood of Skin Examinations

Share this content:

the Cancer Therapy Advisor take:

The likelihood of recent screening for skin cancer among individuals was strongly associated with sociodemographic and constitutional risk factors, according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.

In this study, 50,044 participants of the California Twin Program self-reported data regarding prevalence and determinants of recent clinical screening for skin cancer.

Results showed the reported prevalence of skin examination (32% of participants across all ages reported having a skin examination) was greater than the national estimates.

Major factors significantly associated with recent screening included white race, highest level of education, marital status, number of large moles, and both individual and family history of skin cancer.

Whereas, lower socioeconomic status, racial minority status, and frequent UV-related risk behaviors throughout adulthood correlated to a lower likelihood of recent screening among participants.

Tumor size and estrogen-receptor status contribute greatly to survival improvement in women 70 years
The likelihood of recent screening for skin cancer among individuals strongly associated with sociodemographic and constitutional risk factors.
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. 2Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California. 3Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California.
READ FULL ARTICLE From cebp.aacrjournals.org

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters